Wolf Haldenstein Adler
Recent News About Wolf Haldenstein Adler View More
-
Verve Therapeutics, Inc. (NASDAQ:VERV) Investigation
Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics, Inc. (“Verve” or “the Company”) (NASDAQ:VERV) for violations of the securities laws.